Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial

Background: Glycated hemoglobin (HbA1c) and measures of short-term glycemia do not fully capture daily patterns in plasma glucose dynamics. This study evaluated 24-h glycemic profiles in patients with type 2 diabetes (T2D) initiated on dapagliflozin treatment using continuous glucose monitoring (CGM...

Descripción completa

Detalles Bibliográficos
Autores principales: Henry, Robert R., Strange, Poul, Zhou, Rong, Pettus, Jeremy, Shi, Leon, Zhuplatov, Sergey B., Mansfield, Traci, Klein, David, Katz, Arie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208164/
https://www.ncbi.nlm.nih.gov/pubmed/30222367
http://dx.doi.org/10.1089/dia.2018.0052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208164/
https://www.ncbi.nlm.nih.gov/pubmed/30222367
http://dx.doi.org/10.1089/dia.2018.0052

Ejemplares similares